title: Severe late-onset multisystem cytomegalovirus infection in a premature neonate previously treated for congenital infection.
abstract: BACKGROUND
  Cytomegalovirus is the most common pathogen causing congenital infection and can result in significant neurodevelopmental adverse outcomes. For this reason, it is the standard of care in many regions to treat congenital cytomegalovirus infection involving the brain with six weeks of ganciclovir. There have been no reports in the published literature of significant cytomegalovirus neonatal infection in infants previously treated for congenital infection.
  
  
  METHODS
  A preterm male infant with congenital symptomatic cytomegalovirus infection was initially treated with over 8 weeks of ganciclovir between the ages of 3 and 14 weeks. At four months chronologic age, just prior to planned discharge, he developed an episode of life-threatening multisystem cytomegalovirus disease notable for severe pneumonitis, encephalitis, hepatitis, and disseminated intravascular coagulation. This disease resolved after re-treatment with a prolonged course of intravenous ganciclovir and oral valganciclovir.
  
  
  CONCLUSIONS
  Clinicians should be aware of the possibility of recurrence of congenital cytomegalovirus infection, especially in preterm infants. Serial plasma cytomegalovirus viral load monitoring may have a role in the management of premature infants treated with ganciclovir; had the diagnosis of recrudescent cytomegalovirus infection been considered sooner, specific therapy might have been more quickly initiated and perhaps further morbidity would have been prevented.
authors.affiliation: Division of Infectious Disease, Department of Pediatrics, McMaster University, rm 3A-30 1280 Main St, West, Hamilton, ON L8S 4 K1, Canada. pernica@mcmaster.ca.
authors.forename: Manal F
authors.initials: MF
authors.lastname: El-Sayed
authors.forename: David M
authors.initials: DM
authors.lastname: Goldfarb
authors.forename: Martha
authors.initials: M
authors.lastname: Fulford
authors.forename: Jeffrey M
authors.initials: JM
authors.lastname: Pernica
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D003586:Cytomegalovirus Infections / Q000151:congenital* / Q000188:drug therapy; D015774:Ganciclovir / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D052577:Infant, Extremely Low Birth Weight; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000188:drug therapy* / Q000821:virology; D008297:Male; D012008:Recurrence
chemical_list: D000998:Antiviral Agents; D015774:Ganciclovir
references.citation: J Perinatol. 2012 Jan;32(1):72-4
references.pmid: 22202955
references.citation: BMC Infect Dis. 2010 Feb 11;10:24
references.pmid: 20149232
references.citation: J Infect Dis. 2008 Mar 15;197(6):836-45
references.pmid: 18279073
references.citation: Arch Dis Child Fetal Neonatal Ed. 2009 Jan;94(1):F58-64
references.pmid: 18838466
references.citation: Lancet. 1989 Jun 3;1(8649):1228-31
references.pmid: 2566781
references.citation: J Pediatr. 2010 Aug;157(2):331-3
references.pmid: 20400108
references.citation: J Pediatr. 2003 Jul;143(1):16-25
references.pmid: 12915819
references.citation: Neonatology. 2007;92(4):236-9
references.pmid: 17570943
references.citation: J Perinatol. 2011 Jun;31(6):440-5
references.pmid: 21164427
references.citation: J Perinatol. 2008 Jan;28(1):74-6
references.pmid: 18165832